The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Preliminary Research for Developing a Pattern Identification Tool for Idiopathic Pulmonary Fibrosis

특발성 폐섬유화증 변증 도구 개발을 위한 기초연구

  • Hong, Sung-eun (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Park, Ji-won (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Shin, Jeong-won (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Kil, Jung-eun (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Kwan-il (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Bu, Yung-min (Dept of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University) ;
  • Jung, Hee-jae (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Beom-joon (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University)
  • 홍성은 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 박지원 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 신정원 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 길정은 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 김관일 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 부영민 (경희대학교 한의과대학 본초학교실) ;
  • 정희재 (경희대학교대학원 임상한의학과 폐계내과학교실) ;
  • 이범준 (경희대학교대학원 임상한의학과 폐계내과학교실)
  • Received : 2022.04.04
  • Accepted : 2022.06.28
  • Published : 2022.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study was to develop a standard tool for identifying idiopathic pulmonary fibrosis patterns. Methods: Textbooks, published literature, and references with comments on patterns were reviewed. Using the Delphi method, we determined pattern identification based on the advice of a committee consisting of 11 Korean respiratory internal medicine professors. Results: Four pattern identifications were selected by the Delphi method: qi difficiency (氣虛), yin difficiency (陰虛), phlegm dampness (痰飮), blood stasis (瘀血). The tool was developed in a question-and-answer format containing 38 questions. Conclusions: An IPF pattern identification tool that can analyze IPF patterns for standardized diagnostics was developed with the consent of experts. Further research is needed on its reliability.

Keywords

Acknowledgement

이 논문은 2022년도 한의기반융합기술개발사업의 지원을 받아 수행된 다빈도 난치성 천식 협진 치료 연구(No.HI20C1205)의 지원을 받아 수행된 과제임.

References

  1. Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Interstitial lung disease: NHLBI workshop on the primary prevention of chronic lung diseases. Annals of the American Thoracic Society 2014;11(Supplement 3):169-S177.
  2. Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressivefibrosing interstitial lung diseases. European Respiratory Review 2018;27(150):180076. https://doi.org/10.1183/16000617.0076-2018
  3. Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. The Lancet 2017;389(10082):1941-52. https://doi.org/10.1016/S0140-6736(17)30866-8
  4. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American journal of respiratory and critical care medicine 2011;183(6):788-824. https://doi.org/10.1164/rccm.2009-040GL
  5. Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA. Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). Journal of thoracic disease 2019;11(Suppl 14):S1740-54. https://doi.org/10.21037/jtd.2019.04.62
  6. Ahn JM, Joo HJ, Park JH, Park JW, Kim KI, Jung HJ, et al. The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model. Processes 2020;8(1):102. https://doi.org/10.3390/pr8010102
  7. Hong SE, Kang SW, Park JW, Jang KJ, Park SH, Kim KI, et al. Effects of Korean Medicine in Idiopathic Pulmonary Fibrosis Patients - A Retrospective Chart Review. J Int Korean Med 2021;42(3):375-84. https://doi.org/10.22246/jikm.2021.42.3.375
  8. 전국한의과대학 폐계내과학교실. 폐계내과학. 서울: 도서출판 나도; 2019, p. 464.
  9. 孫忠亮. 肺病學. 上海: 上海科學技術出版社; 1986.
  10. Lee JS. Research methodology 21: Delphi technique. Seoul: Kyoyookbook; 2001.
  11. Jo JS, Kim KN. Development of a Questionnaire for Dietary Habit Survey of Korean Adults. Korean J Community Nutr 2014;19(3):258-73. https://doi.org/10.5720/kjcn.2014.19.3.258
  12. Kang YJ, Park JK, Gu IS. Validation of the self concept and self acceptance test for the people with disabilities. Korea Employment Development Institute for Disabled People, Seongnam, Korea. 2008.
  13. Roh SY. Delphi technique: Predict the future with professional insights. Planning and Policy 2006;299:53-62.
  14. Lawshe CH. A Quantitative Approach To Content Validity. Personnel Psychology 1975;28(4):563-75. https://doi.org/10.1111/j.1744-6570.1975.tb01393.x
  15. 高艳荣, 刘琪, 张炜. 扶正通络方治疗特发性肺纤维化肺肾气虚证临床研究. 辽宁中医药大学学报2020;22(07):172-6.
  16. 李富增, 徐红日, 崔兰凤, 刘国星, 刘畅, 王成祥. 王成祥治疗特发性肺纤维化经验. 世界中西医结合杂志2020;15(04):627-9.
  17. 逢建, 孙钢. 益肺通络方治疗气阴两虚型特发性肺纤维化疗效观察 河北中医. 2018;40(12):1803-6.
  18. 辛大永, 符竣杰. 二甲消癥汤治疗气虚血瘀型特发性肺间质纤维化临床观察. 世界中医药2015;10(05):724-6.
  19. 魏媛, 郭思佳, 王强, 宋雅琳, 孙增涛. 孙增涛教授辨治慢性致纤维化性间质性肺炎经验. 世界中西医结合杂志2019;14(12):1680-4.
  20. 刘崇文. 益气活血法治疗特发性肺纤维化12例. 吉林中医药 2004(05):24-5.
  21. 张南星, 王至婉. 特发性肺纤维化中医证候规律研究. 新中医 2018;50(12):31-5.
  22. 季坤, 马建岭, 史利卿. "肺痿冲剂"治疗特发性肺间质纤维化20例临床疗效观察. 辽宁中医药大学学报 2013;4(15).
  23. 郭素芳. 中医药疗法在特发性肺纤维化治疗中的应用. 中国中医药信息杂志 2008;2(15).
  24. 李辉, 李国勤, 刘俊玲, et al. 益气活血通络法对特发性肺纤维化患者生存质量的影响. 北京中医药大学学报2010;3(33).
  25. 苗青, 丛晓东, 樊茂蓉, 王书臣, 任培中, 张静. 补肾通络汤治疗特发性肺纤维化28例疗效观察. 时珍国医国药2017;2(28).
  26. 薛鸿浩, 张惠勇, 王巍. 益气养阴, 散结化瘀方治疗特发性肺纤维化22例. 光明中医 2017;4(32).
  27. 柴文戍, 李永春. 特发性肺纤维化的诊治进展. 中国现代医学杂志 2003;17(13).
  28. 王步青, 薛勤梅. 通纤方治疗特发性肺纤维化的临床研究. 中国中医急症 2016;2(25).
  29. 王雪利. 谢谋华治疗特发性肺纤维化临床经验. 实用中医药杂志 2014;5.
  30. 王紫娟, 张宇婷, 顾潇枫, et al. 肺纤方加减治疗 36例特发性肺纤维化患者CT积分改变及生活质量影响. 中华中医药杂志 2018;8(33).
  31. 王红岗, 孔繁智. 特发性肺纤维化的现代研究. 浙江中西医结合杂志 2007;2(17).
  32. 于睿智, 吕晓东, 庞立健, 郑钰. 从内伤燥咳论治特发性肺纤维化. 辽宁中医药大学学报 2019;12(21).
  33. 于国强, 石绍顺, 付东升. 旋覆花汤化裁辨治痰瘀痹阻型特发性肺纤维化的临床研究. 中医临床研究 2016;1(8).
  34. 任璐瑶, 孟泳, 贺启萌. 益气活血固本方治疗特发性肺纤维化的临床观察. 中医临床研究 2020;11(12).
  35. 臧建华, 周兆山. 柴胡渗湿汤治疗特发性肺纤维化61例疗效观察. 中医药临床杂志 2015;9(27).
  36. 翟聪慧. 杨毅辨治特发性肺纤维化的经验. 湖北中医杂志 2016;11(38).
  37. 褚栩霞, 杨珺超. 宋康教授治疗特发性肺纤维化经验探析. 浙江中医药大学学报 2017;3(41).
  38. 曹芳, 吴志松, 付小芳, 李慧, 焦扬. 肺痹汤治疗特发性肺间质纤维化咳嗽22例. 环球中医药2015;1.
  39. 曹爱玲, 周贤梅. 周贤梅教授应用五味子汤治疗特发性肺纤维化的临床经验. 吉林中医药 2019;6(39).
  40. 中华中医药学会内科分会, 中国民族医药学会肺病分会, 中华中医药学会肺系病分会. 特发性肺纤维化中医证候诊断标准(2019版). 中医杂志 2020;18(61).
  41. 叶枫. 特发性肺纤维化治疗体会. 四川中医 2002;9(20).
  42. 胡灵芝. 王新华治疗特发性肺纤维化经验介绍. 新中医 2020;1(52).
  43. 严晶晶, 周磊, 管晓舫. 清肺化纤汤对特发性肺纤维化患者肺功能及肺纤维化指标的影响. 中外医学研究 2020;10(18).
  44. 刘莉君, 孙昉昉. 益气活血通络法治疗特发性肺间质纤维化疗效观察. 陕西中医 2016;11(37).
  45. 吴之煌, 张晓霞. 补肺活血汤治疗特发性肺纤维化临床观察. 北京中医药 2010;2(29).
  46. 张桂才, 周贤梅. 特发性肺纤维化中医病机浅析. 光明中医 2013;12(28).
  47. 张宗学, 张伟. "胃不和"与特发性肺纤维化的相关性. 长春中医药大学学报 2015;4(31).
  48. 张海明, 丁浩, 陈瑞. 温阳祛寒通络法治疗肺纤维化体会. 中国中医药信息杂志 2015;4.
  49. 张馨心, 吕晓东, 庞立健, 臧凝子, 邓岳潼. 益气养阴法治疗特发性肺间质纤维化疗效Meta分析. 辽宁中医药大学学报 2020;2(22).
  50. 张树森, 杨柳, 董瑞. 珠及膏治疗特发性肺纤维化气阴两伤型临床观察. 中国中医药现代远程教育 2019;23(17).
  51. 张莹莹, 乔世举. 金龙定喘合剂治疗特发性肺纤维化30例. 中医临床研究 2015;32.
  52. 杨丽梦, 熊旭东. 熊旭东教授中西医结合治疗特发性肺纤维化的临床经验. 中国中西医结合急救杂志 2016;3(23).
  53. 贺启萌, 孟泳, 任璐瑶, 王康, 张萍, 王宁. 孟泳教授益气养阴法治疗特发性肺纤维化经验总结. 智慧健康 2020;2(6).
  54. 陈炜, 张念志, 李国琳. 中医药治疗肺间质纤维化研究进展. 中医药临床杂志 2013;4(25).
  55. 韩萍. 浅谈特发性肺纤维化的中医证治. 现代中医药 2009;5(29).
  56. Kwon BS, Song JW. New Diagnostic Guidelines for Idiopathic Pulmonary Fibrosis. Korean Journal of Medicine 2019;94(2):173-81. https://doi.org/10.3904/kjm.2019.94.2.173
  57. Uh ST. Pathogenesis and New Diagnosis Guideline of Idiopathic Pulmonary Fibrosis. Korean J Med 2009;52(1):22-9.
  58. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. American journal of respiratory and critical care medicine 2000;161(4):1172-8. https://doi.org/10.1164/ajrccm.161.4.9907002
  59. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. British Medical Journal 1990;301(6759):1015-7. https://doi.org/10.1136/bmj.301.6759.1015